Top Midday Decliners

MT Newswires Live11-09

ProPhase Labs (PRPH) said late Thursday it priced an underwritten offering of 4.17 million shares of its common stock, targeting gross proceeds of about $3 million.

Shares slumped past 45%, with intraday trading volume at over 2.1 million compared with a daily average of about 34,000.

Evolent Health (EVH) shares plunged amid heavy trading after Truist Securities cut its price target on the company's stock following Q3 results that fell short of market expectations.

Oppenheimer also adjusted Evolent's price objective to $34 from $45 while maintaining its outperform rating.

Shares of Evolent sank 43% as intraday trading volume jumped to more than 14.4 million versus a daily average of about 2.1 million.

Maravai Lifesciences (MRVI) said late Thursday it agreed to buy Officinae Bio's DNA and RNA business. Financial terms of the deal were not disclosed.

Shares of Maravai slumped 39% as intraday trading volume climbed to over 8.5 million from the stock's daily average of about 1.9 million.

Price: 0.78, Change: -0.65, Percent Change: -45.24

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment